Xylem cuts 2026 earnings-per-share outlook to $5.40–$5.45
Key Facts
Xylem cut its 2026 adjusted earnings-per-share outlook to a range of $5.40 to $5.45, from its previous range of $5.55 to $5.70, after reporting third-quarter results on October 27. Adjusted earnings per share were $1.44, one cent below analysts’ estimate of $1.45, despite rising 5% from the year-earlier period. The company said revenue was affected by project timing and more cautious customer spending decisions. The results also showed order growth and improved profit margins, putting the lower annual outlook alongside stronger operating indicators. Shares fell 4.5% in premarket trading after the results, according to Investing.com’s coverage.
Orders totaled $2.3 billion in the third quarter, up 7% on a reported basis and 10% organically. The increase offers a different picture from the project-timing and customer-spending pressures the company cited in explaining the revenue impact, pointing to higher orders recorded during the period, while the increase did not prevent management from cutting its full-year estimates. The available facts did not include a quarterly revenue figure or a direct comparison with the year-earlier period, so the comparison here focuses on order growth and adjusted earnings guidance. The company also did not provide, in the available facts, a breakdown of the impact attributed to project timing or cautious spending. The annual cut indicates that stronger orders were not enough to change management’s view of full-year results.
At the quarterly profitability level, adjusted EBITDA margin rose 70 basis points year over year to 23.9%. Xylem attributed the margin expansion to productivity savings and strong price realization, whose impact exceeded inflation, lower volumes and product mix. Net income attributable to the company was $291 million, or $1.25 per share, while net income margin increased 320 basis points to 13.2%. Adjusted net income was $336 million, or $1.44 per share, excluding amortization of intangible assets related to acquisition accounting, a loss on the sale of businesses, restructuring and realignment costs, and special charges. Adjusted earnings per share therefore rose from the year-earlier period but fell slightly short of analysts’ estimate.
The lower outlook extends to full-year indicators, but not all in the same direction. Xylem expects adjusted EBITDA margin to be about 23.2% in 2026, up 100 basis points from its adjusted 2025 results. By contrast, it cut its free cash flow margin outlook to about 10.2%, from a previous range of 10.2% to 11%. The new adjusted earnings-per-share range of $5.40 to $5.45 is below the previous forecast of $5.55 to $5.70. The guidance thus combines an expectation of continued improvement in operating profit margin with lower estimates for earnings per share and free cash flow.
The current results also come against a second-quarter backdrop, when the company reported revenue of $2.336 billion versus $2.301 billion in the second quarter of 2025, and net income of $263 million versus $243 million. Those figures show year-over-year growth in revenue and net income in the prior quarter, but do not on their own establish the third-quarter trajectory or explain why the full-year outlook was revised. In its statement, Chief Executive Matthew Pine said, "The resilience we've built, which was clearly on display this quarter, allows us to make those choices intentionally and from a position of strength." The comment came as the company announced strategic steps alongside its results and reduced outlook. XYL shares closed at $108.24 on October 26, before results were published the following day, so that closing price does not reflect a reaction to the announcement.
The announced steps include plans to exit Applied Water International and Specialty Flow Control, alongside a reorganization of the business beginning in 2027 from four segments to three. The new segments will be Treatment and Services, Flow Solutions, and Measurement and Analytics. The company said the activities brought together under this structure include moving, treating, measuring and improving water systems. Xylem presented the reorganization and exits as strategic moves to accelerate growth, while the available facts did not specify a date for completing the exits from the two units. The new segment structure, set to begin in 2027, is the next dated step in the company’s announced plan.